Patients from the prospective Simvastatin and Ezetimibe in Aortic Stenosis ( SEAS ) study with an AVA < 1.0 cm ( 2 ) , MPG40mmHg and EF55 % and asymptomatic at baseline were stratified according to VR with a cut-off value of 0.25 .